A same ethical approval number of SDTHEC2024004013 was found to be shared by three articles [1, 2, 3] from Shandong Cancer Hospital and Institute, an investigation by the 5GH Team reveals.
A same ethical approval number (XMYY-2024KYSB090) in three articles [1, 2, 3] coauthored by YE Guanzhi (叶冠志) et. al., with The First Affiliated Hospital of Xiamen University. However, This ethical approval is questionable.
Arla 预计，全球特殊医学用途配方食品市场在 2024 年至 2030 年保持高速增长（年均增长超过 5%），从 2024 年的 248 亿美元规模增长到 2030 年的约 335 亿美元。而中国市场的年均增长甚至接近 6.6%，从 2024 年的 22.7 亿美元增长到 2030 年的 33.3 亿美元。
Five articles [1, 2, 3, 4, 5] coauthored by ZHAO Mei (赵媚) with the Institute of Psychology, Chinese Academy of Sciences, share the same ethical approval, which was granted on Nov.10th, 2023 with the grant number of H23128. However, this ethical approval is questionable.
The article [1] reports the prevalence of cleft lip and palate (CLP) in Hubei province of China, during 2015 and 2022. However, comparing to the numbers reported in other articles, the prevalence of 0.44‰ reported in article [1] seems to be abnormal.
Abnormal citation patterns are observed on the article [1]
The ethical approval statements on two articles [1, 2] published by the same author group at Wuhan University are found to be problematic.
Problematic ethics statements are found in multiple articles on "Chinese Medicine", a Springer Nature title. Here are some examples
